NUROFEN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NUROFEN Trademark

Serial Number: 97872339 • Registration: 7647505

NUROFEN is a trademark filed by RECKITT & COLMAN (OVERSEAS) HEALTH LIMITED on April 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

RECKITT & COLMAN (OVERSEAS) HEALTH LIMITED (69 trademarks)

SLOUGH, BERKSHIRE SL13UH , GB

Entity Type: 11

Trademark Details

Filing Date

April 4, 2023

Registration Date

January 14, 2025

Published for Opposition

November 26, 2024

Goods & Services

Pharmaceutical preparations and substances, namely, analgesic and anti-inflammatory preparations; and anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; preparations for the relief of symptoms of colds, influenza and allergies; medicated beverages and preparations for making medicated beverages for the treatment of colds and flu, sinus congestion, sore throats, and coughs; skin transdermal patches featuring medication for the treatment of pain and symptoms of cold and flu; adhesive skin patches featuring medication for the treatment of pain and symptoms of cold and flu

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2024 CRFA
ASSIGNED TO LIE
Oct 21, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 9, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 4, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 4, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 4, 2024 CNSL
ASSIGNED TO EXAMINER
Dec 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2023 NWOS
NEW APPLICATION ENTERED
Apr 7, 2023 NWAP